About Eli Lilly and Company Common Stock
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named. The company is ranked 4th on the list of largest biomedical companies by revenue and is the most valuable pharmaceutical company worldwide.
2BB score and signals
Eli Lilly and Company Common Stock’s current 2BB score is 44 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 34 | Low |
| Momentum | 36 | Weakening |
| Financial strength | 87 | Very Strong |
| Quality | 100 | Very Strong |
| Risk | 35 | Low |
Company facts
| CEO | David A. Ricks |
| Headquarters | Indianapolis, Indiana, United States |
| Founded | 1876 |
| Employees | 50K |
| P/E ratio | 39.47 |
| 52-week range | $712.05 – $1,292.65 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-02-02 | — | 10.0402 | — | $23.36B |
| 2026-10-29 | — | 9.8772 | — | $22.40B |
| 2026-08-05 | — | 6.0661 | — | $20.93B |
| 2026-04-30 | — | 7.3182 | — | $17.64B |
Related companies
